Microarrays in Limbo | GenomeWeb

Microarrays in Limbo

The votes are in and it would seem that the research community hasn't quite made up its mind about what to do with microarrays just yet.

In a recent poll conducted by the RNA-Seq Blog, about half of 175 total respondents, or 88 voters, declared that microarrays are here to stay, while the remaining 50 percent, or 87 voters, believe that its time is over.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.